IL6 and prostate carcinoma: In last years, it was observed that IL-6 play a crucial role in MDR (multi drug resistance) processes; in fact stimulation of androgen sensitive and insensitive prostate cancer cells with IL-6 determine, trough nuclear factor kappaB (NF-kappaB) activation, induce resistance to docetaxel treatments [37].